Shandong Sito Bio-technology Co (SZSE:300583) Interest Expense : ¥-29.3 Mil (TTM As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Shandong Sito Bio-technology Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Shandong Sito Bio-technology Co's interest expense for the three months ended in Mar. 2025 was ¥ -8.8 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-29.3 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Shandong Sito Bio-technology Co's Operating Income for the three months ended in Mar. 2025 was ¥ -12.9 Mil. Shandong Sito Bio-technology Co's Interest Expense for the three months ended in Mar. 2025 was ¥ -8.8 Mil. Shandong Sito Bio-technology Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shandong Sito Bio-technology Co Interest Expense Historical Data

The historical data trend for Shandong Sito Bio-technology Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Sito Bio-technology Co Interest Expense Chart

Shandong Sito Bio-technology Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-33.98

-30.21

-36.89

-37.66

-30.85

Shandong Sito Bio-technology Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Interest Expense	Get a 7-Day Free Trial															-10.37	-6.29	-6.23	-7.96	-8.77

Shandong Sito Bio-technology Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-29.3 Mil.

Shandong Sito Bio-technology Co (SZSE:300583) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shandong Sito Bio-technology Co's Interest Expense for the three months ended in Mar. 2025 was ¥-8.8 Mil. Its Operating Income for the three months ended in Mar. 2025 was ¥-12.9 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was ¥73.3 Mil.

Shandong Sito Bio-technology Co's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Shandong Sito Bio-technology Co did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Shandong Sito Bio-technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Sito Bio-technology Co Ltd (SZSE:300583) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

South Section of East Outer Ring Road, Dingtao District, Shandong Province, Heze, CHN, 274100

Website

http://www.sitobiotech.com

Shandong Sito Bio-technology Co Ltd is a biotechnology company. It uses genetic engineering technology and microbial transformation technology to develop and produce steroid drug raw materials, specialty respiratory raw materials and finished preparations, and other drug intermediaries. The company operates in the following business segments; intermediates, high-end specialty respiratory APIs, and preparations. Its product offerings include androstenedione (AD), 9-hydroxy androstenedione (90H-AD), 17a-hydroxyprogesterone derivatives (A ring), and bi-decanoic acid (BA), and others. In addition, the company holds patents for various APIs and other intermediaries.

Executives

Mi Qi	Directors, executives
Wang Min	Director
Kong Qing Zhi	Executives
He Jian Yong	Directors, executives
Ceng Qing Li	Securities Affairs Representative

Shandong Sito Bio-technology Co Headlines

No Headlines